Big drops in the rates of HPV infections in teenage girls and young women!
Nationally representative data through 2018 indicate that HPV vaccine-type prevalence continues to decline among females aged 14–19 (88%) and 20–24 (81%) years compared with before vaccination.
And we will hopefully continue to have more and more people getting vaccinated and protected with these vaccines that can prevent cancer!
A One Dose HPV Vaccine Schedule
What’s next?
“The 4-7 April convening of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been emerging over past years that single-dose schedules provide comparable efficacy to the two or three-dose regimens.
SAGE’s review concluded that a single-dose Human Papillomavirus (HPV) vaccine delivers solid protection against HPV, the virus that causes cervical cancer, that is comparable to 2-dose schedules. This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls”
One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer
Believe it or not, we may soon be moving to a one-dose HPV vaccine schedule!
“A single-dose HPV vaccination schedule has the potential to reach more girls and avert a greater number of cervical cancer cases than reaching fewer girls with a two-dose regimen.”
Frequently asked questions about single dose HPV vaccination
In fact, several countries are already using a one-dose HPV vaccine schedule, including Australia, England, and Scotland…
Source: A One-Dose HPV Vaccine Schedule – VAXOPEDIA
You must be logged in to post a comment.